0001104659-18-002870.txt : 20180118
0001104659-18-002870.hdr.sgml : 20180118
20180118163625
ACCESSION NUMBER: 0001104659-18-002870
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180116
FILED AS OF DATE: 20180118
DATE AS OF CHANGE: 20180118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BADDOUR LINDA
CENTRAL INDEX KEY: 0001181151
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36732
FILM NUMBER: 18534336
MAIL ADDRESS:
STREET 1: PRA INTERNATIONAL
STREET 2: 12120 SUNSET HILLS ROAD, SUITE 600
CITY: RESTON
STATE: VA
ZIP: 20190
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRA Health Sciences, Inc.
CENTRAL INDEX KEY: 0001613859
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 463640387
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4130 PARKLAKE AVENUE
STREET 2: SUITE 400
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 9197868200
MAIL ADDRESS:
STREET 1: 4130 PARKLAKE AVENUE
STREET 2: SUITE 400
CITY: RALEIGH
STATE: NC
ZIP: 27612
4
1
a4.xml
4
X0306
4
2018-01-16
0
0001613859
PRA Health Sciences, Inc.
PRAH
0001181151
BADDOUR LINDA
C/O PRA HEALTH SCIENCES, INC.
4130 PARKLAKE AVENUE, SUITE 400
RALEIGH
NC
27612
0
1
0
0
Executive VP & CFO
Common Stock
2018-01-16
4
M
0
67000
11.73
A
67000
D
Common Stock
2018-01-16
4
S
0
64405
90.26
D
2595
D
Common Stock
2018-01-16
4
S
0
2595
90.56
D
0
D
Stock Option (Right to Buy)
11.73
2018-01-16
4
M
0
39374
0
D
2023-12-20
Common Stock
39374
39931
D
Stock Option (Right to Buy)
11.73
2018-01-16
4
M
0
27626
0
D
2023-12-20
Common Stock
27626
117669
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $89.54 to $90.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $90.54 to $90.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The options vested on September 23, 2017.
The options vested on March 2, 2016 upon satisfaction of certain performance criteria.
By: /s/ Timothy J. McClain, by power of attorney
2018-01-18